Cyrille Leperlier
Director/Board Member bei NUCANA PLC
Vermögen: - $ am 31.03.2024
Profil
Cyrille Raymond George Leperlier is currently the Chief Executive Officer at Divlal SAS since 2020 and an Independent Non-Executive Director at NuCana Plc since 2018.
Previously, he worked as a Medical Director at Rhone-Poulenc Rorer, Inc. and Sanofi-Aventis Japan from 2004 to 2019, where he held the position of Medical Director from 2014 to 2019.
He obtained a graduate and doctorate degree from the University of Paris Jussieu.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
NUCANA PLC
-.--% | 31.12.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Cyrille Leperlier
Unternehmen | Position | Beginn |
---|---|---|
NUCANA PLC | Director/Board Member | 01.05.2018 |
Divlal SAS | Chief Executive Officer | 01.06.2020 |
Ehemalige bekannte Positionen von Cyrille Leperlier
Unternehmen | Position | Ende |
---|---|---|
Sanofi-Aventis Japan | Chief Tech/Sci/R&D Officer | 01.12.2019 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Cyrille Leperlier
University of Paris Jussieu | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NUCANA PLC | Health Technology |
Private Unternehmen | 3 |
---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
Sanofi-Aventis Japan | |
Divlal SAS |